Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.

Jennifer Powers is a Plastic Surgeon and a Dermatologist in Baltimore, Maryland. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Pityriasis Rubra Pilaris, and Squamous Cell Skin Carcinoma.

Jun Kang is a Dermatologist in Baltimore, Maryland. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Localized Scleroderma.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid.

Dr. Damon S. Cooney is an associate professor of plastic and reconstructive surgery at the Johns Hopkins University School of Medicine. Dr. Cooney performs all types of general plastic surgery but specializes in microvascular reconstruction (free flaps). A particular focus of his clinical practice is improving the functional and aesthetic results of head and neck reconstruction. He completed additional fellowship training at the University of Pittsburgh to become an expert in microsurgical techniques for reconstructing the extremities, trunk, breast, and head and neck following traumatic and/or oncological defects. Dr. Cooney earned a Ph.D. from Ohio State University Department of Molecular, Cellular and Development Biology. Dr. Cooney’s clinical and basic research focus is composite tissue allotransplantation (CTA). He is a member of the Composite Tissue Allotransplantation team at Johns Hopkins and helps conduct human hand and face transplantation trials. His laboratory work includes engineering human tissues for reconstructive purposes, nerve regeneration, microsurgical education and inducing tolerance in order to reduce or eliminate the need for systemic immunosuppression in transplantation patients. Dr. Cooney has published numerous peer-reviewed articles and book chapters in addition to being a reviewer for plastic surgery journals. He is a founding member of the American Society for Reconstructive Transplantation. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Keloids, Hidradenitis Suppurativa, Squamous Cell Skin Carcinoma, Osteotomy, and Abdominal Wall Surgery.

Daniel Synkowski is a Dermatologist in Baltimore, Maryland. Dr. Synkowski is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Hidradenitis Suppurativa, Melanoma, Actinic Keratosis, and Warts.

Robert Smith is a Pediatrics specialist and a Dermatologist in Baltimore, Maryland. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Hidradenitis Suppurativa, Bullous Pemphigoid, Acne, and Cutaneous Lupus Erythematosus (CLE).

Dr. Kofi Derek Owusu Boahene is a professor of otolaryngology-head and neck surgery and dermatology at the Johns Hopkins University School of Medicine. He is the Director of the Division of Facial Plastics and Reconstructive Surgery and the director for the facial plastics fellowship training program. His practice encompasses the entire spectrum of facial plastic and reconstructive surgery including cosmetic and reconstructive aspects. Dr. Boahene is a leading expert in facial paralysis surgery and facial nerve injuries and has pioneered innovative treatment protocols and surgical techniques in facial reanimation. He is the director of the Johns Hopkins Facial Nerve center dedicated to restoring facial balance, symmetry and animation to those who have suffered from facial paralysis and facial nerve disorders. As an expert microsurgeon, Dr. Boahene routinely performs some of the most complex facial reconstruction procedures on the face including rebuilding of an entire nose, lip, jaw and facial defects resulting from cancer treatment, traumatic injuries or as a result of birth defects. He uses cutting edge 3-D technology, image-guided technology and tissue transplanted from other parts of the body to restore or replace missing tissues. He is a key member of the Johns Hopkins facial transplant program. His cosmetic experience is broad and draws from patients across the globe. He routinely performs rhinoplasties, eyelid surgery, face lifts and other facial enhancing procedures. As a skull base surgeon, Dr. Boahene has pioneered minimally invasive techniques for removal of skull base and brain tumors, repairing CSF leaks and has authored a major textbook on this subject. Dr. Boahene received his undergraduate degree from the University of Central Arkansas. He graduated summa cum laude from Meharry Medical College in Nashville, Tennessee, completed a five-year surgical residency training program in otolaryngology-head and neck surgery at the Mayo Clinic in Rochester, Minnesota, and received fellowship training in facial plastic and reconstructive surgery at the University of Minnesota. As the recipient of the prestigious Mayo Brothers Distinguished Fellowship Award, Dr. Boahene was awarded additional craniofacial surgery training in Adelaide, Australia. He also received the Jack R. Anderson Prize for Scholastic Excellence for attaining the highest score nationally on the American Academy of Facial Plastic and Reconstructive Surgery certification exam. Dr. Boahene serves as on the Board of Governors or the American Academy Facial Plastic and Reconstructive Surgery. He is a member of several professional organizations, including the American Academy of Facial Plastic and Reconstructive Surgery and the American Academy of Otolaryngology-Head and Neck Surgery. In 1993, Dr. Kofi Boahene received the Alpha Omega Alpha Medical. Dr. Boahene is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, Septoplasty, and Gastrostomy.

Dr. Sima Rozati is an Assistant Professor of Dermatology at the Johns Hopkins University School of Medicine. She specializes in medical dermatology, cutaneous lymphoma, and supportive oncodermatology. She received her medical degree from the Shahid Beheshti University of Medical Sciences in Tehran. After completing her internal medicine residency at the Cleveland Clinic, she completed a research fellowship and PhD in cutaneous lymphoma at the University Hospital of Zürich in Switzerland. She returned to the U.S. where she completed cutaneous lymphoma fellowship, under the mentorship of Dr. Youn Kim, followed by dermatology residency at Stanford University School of Medicine in California. In a multidisciplinary environment, Dr. Rozati aims to provide excellent care to patients with cutaneous lymphoma and cancer whom are experiencing cutaneous adverse events from targeted therapies, immune- and chemotherapies. Dr. Rozati’s research interest focuses on cutaneous lymphoma, understanding the biology of this heterogeneous group of malignancies by analyzing the mutational and epigenetic landscape. Her translational research efforts is directed to investigate novel targeted and immunotherapeutic for cutaneous T cell lymphoma. She is a member of different professional organizations, including the American Academy of Dermatology and Woman’s dermatologic Society. Dr. Rozati is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Localized Scleroderma.

Sashank Reddy is an associate professor and vice chair of research in the Johns Hopkins Department of Plastic and Reconstructive Surgery and has a secondary appointment in the Department of Biomedical Engineering. He also serves as medical director for Johns Hopkins Technology Ventures. His areas of clinical expertise include craniofacial reconstruction, facial aesthetics and headache surgery. Dr. Reddy received his undergraduate degree with university honors from Johns Hopkins, where he pursued biology and humanistic studies as a Hodson Scholar. He went on to complete M.D. and Ph.D. studies at Harvard Medical School and the Massachusetts Institute of Technology under the auspices of the National Institutes of Health Medical Scientist Training Program. Dr. Reddy then completed a residency in the Johns Hopkins/University of Maryland integrated plastic surgery training program, and a craniofacial fellowship at Johns Hopkins and the R Adams Cowley Shock Trauma Center. He joined the Johns Hopkins faculty in July 2018. In addition to his clinical practice in plastic surgery, Dr. Reddy directs a research laboratory in regenerative medicine. Current studies center on mechanisms of regeneration and homeostasis in skin, and development of nanomaterials to support tissue regeneration and cell therapy. His discoveries have been published in leading journals including Nature, Cell, Cell Stem Cell and Science Translational Medicine. Dr. Reddy is also an accomplished entrepreneur and biomedical innovator. In his role as medical director for Johns Hopkins Technology Ventures, he advises faculty and university administration on enhancing the impact of discoveries through company creation and corporate partnerships. A member of the American Society of Plastic Surgeons and the American Society of Maxillofacial Surgeons, Dr. Reddy serves on boards and committees in the organizations. He is a former American Society of Plastic Surgeons alternate delegate to the American Medical Association. In his leadership, scholarship and clinical efforts, Dr. Reddy — who has received numerous accolades from professional societies — seeks to integrate science and medicine for the benefit of patients. Videos Sashank Reddy, M.D., Ph.D.Plastic and Reconstructive Surgeon Surgery for Chronic Headaches: Is it Right for You? Recent News Articles and Media Coverage Botulinum Toxin Injectables for Migraines This injectable gel could one day rebuild muscle, skin, and fat, Science (2019) This Johns Hopkins startup has a new way to regrow soft tissue, Technical.ly Baltimore (2017) Hopkins startup looks to help regrow human tissue with new technology, Baltimore Business Journal (2017) Hopkins entrepreneurs, alums land on Baltimores ’40 under 40’ list, Johns Hopkins HUB (2017) Say hello to the BBJ’s 2017 class of 40 under 40 honorees, Bizjournals (2017). Dr. Reddy is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer and Nerve Decompression.

Dr. Howard Hines is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology, melanoma and psoriasis. He received his B.A. in biology from Western Maryland College and his M.D. from the University of Maryland School of Medicine. He completed his residency in general internal medicine at Washington Hospital Center and performed a fellowship in dermatology at George Washington University Hospital. Dr. Hines is a member of several professional organizations, including the American Medical Association, American College of Physicians and American Society of Internal Medicine. CV http://www.hopkinsmedicine.org/dermatology/our_experts/_documents/Howard_C_Hines_Curriculum_vitae.doc Selected Publications Boudreau S, Hines HC, Hood AF. “Dermal abscess with staphylococcus aureus, cytomegalovirus, and acid-fast bacilli in a patient with acquired immunodeficiency syndrome.” Journal of Cutaneous Pathology. 1988;15:53-57. Horn TD, Hines HC. “Erythrophagocytosis in the skin: case report.” Journal of Cutaneous Pathology. 1988;15:399-403. Jawitz JC, Hines HC. “Treatment of eczema herpeticum with systemic acyclovir.” Archives of Dermatology. February 1985;121:274-275. Dr. Hines is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Pigmented Purpuric Dermatosis, Actinic Keratosis, Liver Spots, and Universal Acquired Melanosis.

Dr. Jaroslaw Jedrych is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatopathology and anatomic pathology. Dr. Jedrych received his M.D. from the Warsaw Medical University. He completed his residency in anatomic pathology at Yale School of Medicine, where he served as chief resident. He then completed his fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center, where he served as chief fellow, and a dermatopathology fellowship at University of Pittsburgh Medical Center. Dr. Jedrych is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Epidermodysplasia Verruciformis, Trichoepithelioma, Warts, and Grover's Disease.

Dr. Sewon Kang is the Noxell Professor and Chairman of the Department of Dermatology at the Johns Hopkins University School of Medicine and the Dermatologist-in-Chief of Johns Hopkins Hospital. He is also founder and co-Director of the Cutaneous Translational Research Program (CTReP) at Hopkins. A recipient of the Dermatology Foundation's Career Development Award, he has received other research awards and grants from the American Dermatological Association, the National Psoriasis Foundation and the National Institutes of Health (Roadmap T32, K24, and R01). His research focus has been in the areas of skin pharmacology and photomedicine. He is the Past President of the Photomedicine Society, and the American Acne and Rosacea Society. Dr. Kang is or has been on the Board of Directors of multiple organizations including, the Society for Investigative Dermatology, the Association of Professors of Dermatology, the Dermatology Foundation, and the Skin of Color Society. An author on over 240 publications and book chapters, Dr. Kang is also the Editor-in-Chief of the 9th edition of the Fitzpatrick's Dermatology textbook. He is an inventor/co-inventor of 17 patents and has given over 300 presentations globally. A graduate with honors from Williams College and the University of Michigan, Dr. Kang completed dermatology residency and fellowship at the Harvard Medical School/Massachusetts General Hospital. He sees patients exclusively at the Johns Hopkins Hospital, and his areas of clinical expertise include photomedicine, skin cancer (melanoma), skin aging, and dermatology for ethnic skin. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Acne, Prurigo Nodularis, and Rosacea.

Julie Deutsch is a Pathologist and a Dermatologist in Baltimore, Maryland. Dr. Deutsch has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer and Melanoma.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

George Grace is a Plastic Surgeon in Baltimore, Maryland. Dr. Grace is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Breast Enlargement In Males, Squamous Cell Skin Carcinoma, and Keloids.

Albert Zhou is a Dermatologist in Baltimore, Maryland. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Acute Febrile Neutrophilic Dermatosis.

Zaineb Makhzoumi is a Dermatologist in Baltimore, Maryland. Dr. Makhzoumi is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Actinic Keratosis. Dr. Makhzoumi is currently accepting new patients.